Psychiatrists are frequently asked about the potential uses of cannabis and cannabinoid products to treat mental illnesses. To help inform members and educate the public, the CPA has systematically reviewed the existing literature on RCTs examining potential beneficial uses of cannabis and cannabinoid products to treat mental illness in adults. Read ...
September 9, 2020Rob Cornforth
—Ottawa, ON, April 12, 2017— With the federal government set to legalize marijuana on or before July 1, 2018, the Canadian Psychiatric Association (CPA) has released a statement today highlighting the importance of safeguarding the mental wellness of youth and young adults in the forthcoming legislation. “There is a strong evidence-base ...
April 12, 2017Rob Cornforth